PMID- 24368670 OWN - NLM STAT- MEDLINE DCOM- 20140408 LR - 20211021 IS - 1522-1555 (Electronic) IS - 0193-1849 (Print) IS - 0193-1849 (Linking) VI - 306 IP - 4 DP - 2014 Feb 15 TI - Characterization of the adverse effects of nicotine on placental development: in vivo and in vitro studies. PG - E443-56 LID - 10.1152/ajpendo.00478.2013 [doi] AB - In utero exposure to nicotine is associated with increased risk of numerous adverse fetal and neonatal outcomes, which suggests that it acts directly to affect placental development and the establishment of the fetomaternal circulation (FC). This study used both in vivo [Wistar rats treated with 1 mg/kg nicotine from 2 wk prior to mating until gestational day (GD) 15] and in vitro (RCHO-1 cell line; treated with 10(-9) to 10(-3)M nicotine) models to examine the effects of nicotine on these pathways. At GD 15, control and treated placentas were examined for the impact of nicotine on 1) trophoblast invasion, proliferation, and degree of hypoxia, 2) labyrinth vascularization, 3) expression of key genes of placental development, and 4) expression of placental angiogenic factors. The RCHO-1 cell line was used to determine the direct effects of nicotine on trophoblast differentiation. Our in vivo experiments show that nicotine inhibits trophoblast interstitial invasion, increases placental hypoxia, downregulates labyrinth vascularization as well as key transcription factors Hand1 and GCM1, and decreases local and circulating EG-VEGF, a key placental angiogenic factor. The in vitro experiments confirmed the inhibitory effects of nicotine on the trophoblast migration, invasion, and differentiation processes and demonstrated that those effects are most likely due to a dysregulation in the expression of nicotine receptors and a decrease in MMP9 activity. Taken together, these data suggest that adverse effects of maternal smoking on pregnancy outcome are due in part to direct and endocrine effects of nicotine on the main processes of placental development and establishment of FC. FAU - Holloway, A C AU - Holloway AC AD - Centre National de la Recherche Scientifique, Grenoble, France; FAU - Salomon, A AU - Salomon A FAU - Soares, M J AU - Soares MJ FAU - Garnier, V AU - Garnier V FAU - Raha, S AU - Raha S FAU - Sergent, F AU - Sergent F FAU - Nicholson, C J AU - Nicholson CJ FAU - Feige, J J AU - Feige JJ FAU - Benharouga, M AU - Benharouga M FAU - Alfaidy, N AU - Alfaidy N LA - eng GR - R01 HD020676/HD/NICHD NIH HHS/United States GR - FRN 94331/CAPMC/CIHR/Canada GR - MOP 86474/CAPMC/CIHR/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131224 PL - United States TA - Am J Physiol Endocrinol Metab JT - American journal of physiology. Endocrinology and metabolism JID - 100901226 RN - 0 (Basic Helix-Loop-Helix Transcription Factors) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (helix-loop-helix protein, eHAND) RN - 6M3C89ZY6R (Nicotine) SB - IM MH - Animals MH - Basic Helix-Loop-Helix Transcription Factors/metabolism MH - Cell Line MH - Cell Proliferation/drug effects MH - Female MH - Nicotine/*pharmacology MH - Placenta/*drug effects/metabolism MH - Placentation/*drug effects MH - Pregnancy MH - Rats MH - Rats, Wistar MH - Trophoblasts/cytology/*drug effects/metabolism MH - Vascular Endothelial Growth Factor A/metabolism PMC - PMC4865199 OTO - NOTNLM OT - endocrine gland-derived vascular endothelial growth factor OT - matrix metalloproteinase 9 OT - nicotinic acetylcholine receptors OT - rat placentation OT - trophoblast invasion and differentiation EDAT- 2013/12/26 06:00 MHDA- 2014/04/09 06:00 PMCR- 2015/02/15 CRDT- 2013/12/26 06:00 PHST- 2013/12/26 06:00 [entrez] PHST- 2013/12/26 06:00 [pubmed] PHST- 2014/04/09 06:00 [medline] PHST- 2015/02/15 00:00 [pmc-release] AID - ajpendo.00478.2013 [pii] AID - E-00478-2013 [pii] AID - 10.1152/ajpendo.00478.2013 [doi] PST - ppublish SO - Am J Physiol Endocrinol Metab. 2014 Feb 15;306(4):E443-56. doi: 10.1152/ajpendo.00478.2013. Epub 2013 Dec 24.